Transient Upregulation of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Human Chorionic Gonadotropin Downregulates Autoimmune Diabetes

Diabetes - United States
doi 10.2337/db06-1727
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Indoleamine 2,3-Dioxygenase Is a Signaling Protein in Long-Term Tolerance by Dendritic Cells

Nature Immunology
AllergyImmunology
2011English

Induction of Indoleamine 2,3-Dioxygenase by Interferon- In Human Islets

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

The Modulation of Enzyme Indoleamine 2,3-Dioxygenase From Dendritic Cells for the Treatment of Type 1 Diabetes Mellitus

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Fludarabine Downregulates Indoleamine 2,3-Dioxygenase in Tumors via a Proteasome-Mediated Degradation Mechanism

PLoS ONE
Multidisciplinary
2014English

Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates With Antitumor Responses

Cancer Research
Cancer ResearchOncology
2007English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Inhibition of Experimental Asthma by Indoleamine 2,3-Dioxygenase

Journal of Clinical Investigation
Medicine
2004English

Induction of Pulmonary Indoleamine 2,3-Dioxygenase by Interferon.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy